|
|
|
|
|
by phobosanomaly
2019 days ago
|
|
I'd also like to provide a different perspective from another scientist at Pfizer/BioNTech. While Mr. Bourla is a 'business executive and veterinarian', another member of the Pfizer/BioNTech team has a different perspective. Uğur Şahin MD, chief executive of Germany’s BioNTech, whose main field of research is cancer research and immunology, and whose company actually developed the underlying technology of the mRNA vaccine jointly released with Pfizer had this to say: '“I’m very confident that transmission between people will be reduced by such a highly effective vaccine — maybe not 90% but maybe 50%,” he said.' https://apnews.com/article/europe-coronavirus-pandemic-1e199... He is wwwaaaayyyyy more qualified to have insight into the efficacy of the vaccine than a CEO and vet who has never done research in or treated human patients in the field of immunology. |
|